Novartis Announces Intention to Spin Off Alcon

Novartis has announced that they intend to seek shareholder approval to spin off 100% of Alcon's eye care device business into a standalone,...

Read More

Novartis Delivers Strong First Quarter in 2018

Net sales for the first quarter of 2018 were CAD 161 billion, an increase of 4% at constant currencies Core operating income also grew by...

Read More

Novartis Delivered Solid 2016 Performance, Alcon Q4 Sales Flat

Sales were in line with last fiscal year due to strong performances from growth products (Cosentyx, Entresto, Gilenya, oncology, Sandoz...

Read More

Novartis on Alcon: All Options are Open

Reuters reported yesterday, that Swiss parent of Alcon, drugmaker Novartis is considering the sale of its eye care unit Alcon  The source is an...

Read More

Alcon Expands Glaucoma Treatment Portfolio by Acquiring Transcend Medical

Alcon announced that it has entered into an agreement to acquire Transcend Medical, Inc, a privately-held, US-based company focused on developing...

Read More